(Health-NewsWire.Net, May 27, 2016 ) Publisher's, 'Psychosis - Pipeline Review, H1 2016', provides an overview of the Psychosis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Psychosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Psychosis and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Psychosis - The report reviews pipeline therapeutics for Psychosis by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Psychosis therapeutics and enlists all their major and minor projects - The report assesses Psychosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Psychosis
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001242072/sample
Table of Content: An Overview
Table of Contents 2 List of Tables 5 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Psychosis Overview 7 Therapeutics Development 8 Pipeline Products for Psychosis - Overview 8 Psychosis - Therapeutics under Development by Companies 9 Psychosis - Pipeline Products Glance 10 Late Stage Products 10 Clinical Stage Products 11 Early Stage Products 12 Psychosis - Products under Development by Companies 13 Psychosis - Companies Involved in Therapeutics Development 14 Acadia Pharmaceuticals Inc. 14 Addex Therapeutics Ltd 15 Evotec AG 16 Gabather AB 17 Glenmark Pharmaceuticals Ltd. 18 Heptares Therapeutics Limited 19 Integrative Research Laboratories Sweden AB 20 Merck & Co., Inc. 21
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001242072/discount
Newron Pharmaceuticals S.p.A. 22 Reviva Pharmaceuticals Inc. 23 Sumitomo Dainippon Pharma Co., Ltd. 24 Sunovion Pharmaceuticals Inc. 25 Wuhan Docan Pharmaceutical Co., Ltd 26 Psychosis - Therapeutics Assessment 27 Assessment by Monotherapy Products 27 Assessment by Target 28 Assessment by Mechanism of Action 30 Assessment by Route of Administration 32 Assessment by Molecule Type 33 Drug Profiles 34 ADX-88178 - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 CB-0306 - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Drug to Agonize Muscarinic M1 and M4 Receptors for Psychosis and Neurologic Diseases - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001242072/buy/2000
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|